Company Profile About Us VISGENEER is a biotech company located in Hsinchu, Taiwan, and is granted as an "Enterprises in the Newly Emerging, Important and Strategic Industries (#09500828690) " by the ministry of Economic. Visgeneer aims to develop and produce biomedical products associated with human diseases (cancer, cardiovascular disease, diabetes and gout etc.) and skin aging. Visgeneer has generated a bioinformatic database associated with cancer. We are currently using this database as a source to develop high sensitive, specific molecular diagnosing products and we will further develop antibodies in association with pharmaceutical process for disease treatments. Visgeneer (ISO13485:2003) has produced a fast, low sample volume and portable biosensor for monitoring blood glucose level and we will further develop multi-functional monitoring system for measuring the levels of blood pressure, cholesterol and uric acid. We are also actively participated in the development of non-invasive blood glucose monitoring system. Visgeneer (ISO9001:2000) has utilized nano tech water (total oxidizable carbon <1 ppb; 0~5 particles greater than 0.05 μm/ml; bacteria <1 cfu/l; Metals <1 ppt; resistivity 18.24 M.cm; 17 O NMR (Nuclear Magnetic Resonance) linewidth 58.7 Hz) provided by Industrial Technology Research Institute as a carrier in combination of several functional animal/plant extracts to produce high quality skin care cosmetic products to satisfy the needs of all ages. Thinking globally, Visgeneer will provide high quality biomedical products world-widely through an establishment of relationships with research institutes, hospitals, pharmaceutical factories and distributors.
Products
No 335, Sec. 6, Zhonghua Rd., Xiangshan Dist., Hsinchu City, 30094, TAIWAN,
30094 Hsinchu City
× × × × × × ×
![Please login or create a free account to see this information.](data:image/png;base64,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)